Posters

Choose an Event

ASM 2010

Evolution of Serotypes among Macrolide Resistant Streptococcus pneumoniae(SPN) and Coverage of the 7-Valent SPN conjugate vaccine (PCV7) in Canada from 1998 to 2008

A.K. Wierzbowski, P. Lagacé-Wiens, N. Laing, D.J. Hoban, G.G. Zhanel and The Canadian Antimicrobial Resistance Alliance (CARA)

PDF 128Mb Download

 

Characterization of Carbapenem Reduced-Susceptible (CRS) E. coli (EC) and K. pneumoniae (KP) from Canadian Hospitals: CANWARD 2007 and 2008

F. Tailor, P.J. Simner, L. Mataseje, M.R. Mulvey, D.J. Hoban, J. A. Karlowsky and G.G. Zhanel

PDF 324Mb Download

 

Activity of Oritavancin Against S. aureus, S. epidermidis, Enterococcus spp. and S. pneumoniae Isolated from Canadian Hospitals: Results of CANWARD 2007-2009

G.G. Zhanel, K. Nichol, P. Lagacé-Wiens, M. DeCorby, R. Vashisht, J.A. Karlowsky and D.J. Hoban

PDF 87.0Mb Download

 

Comparison of Virulence Factors & Antimicrobial Susceptibilities Among ST131 and non-ST131 ESBL-producing E. coli

Patricia J. Simner, Shelley Peterson, Johann Pitout, George G. Zhanel and Daryl J. Hoban

PDF 208Mb Download

 

ICAAC 2011

Comparison of Community-Associated and Healthcare-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) in Canada: CANWARD 2007-2010

K.A. Nichol, H.J. Adam, M. Mccracken, L. Mataseje, M.R. Mulvey, M.R. Baxter, D.J. Hoban and G.G. Zhanel

PDF 285Kb Download

 

Antifungal Susceptibility of Candida Blood Culture Isolates from Canadian Hospitals: Results of the CANWARD 2007 and 2010 study

J. Fuller, L. Turnbull, S. Shokoples, R. Rennie, M. Baxter, H. Adam, D. J. Hoban and G. G. Zhanel

PDF 137Kb Download

 

Activity of Doripenem (DOR) Against Molecularly Characterized AmpC and ESBL Producing Escherichia coli (EC) Including Strains with Reduced Susceptibility to Carbapenems (CRS) from Canadian Hospitals: CANWARD 2007-2010

F. Tailor, P. J. Simner, L. Mataseje, M. R. Mulvey, P. Lagacé-Wiens, M. Decorby, B. Weshnoweski, R. Vashisht1, N. Laing, D. J. Hoban and G. G. Zhanel

PDF 351Kb Download

 

 

The 13-valent Pneumococcal Conjugate Vaccine Provides Excellent Coverage of Multi-drug Resistant Streptococcus pneumoniae in Canada

H.J. Adam, K.A. Nichol, A.K. Wierzbowski, N.M. Laing, I. Martin, M. Gilmour, W. Demczuk, D.J. Hoban and G.G. Zhanel

PDF 306Kb Download

 

Activity of Telavancin against Gram-Positive Cocci from Canadian Hospitals: CANWARD 2007-2010

K.A. Nichol, N. Laing, B. Weshnoweski, R. Vashisht, M.R. Baxter, H.J. Adam, D.J. Hoban and G.G. Zhanel

PDF 163Kb Download

 

 

Vancomycinand DaptomycinMIC Creep in Staphylococcus spp.in Canada –Analysis of 4642 S. aureus and 497 S. epidermidis isolates from 2007 –2010

Philippe Lagacé-Wiens, Heather Adam, Kim Nichol, Melanie Decorby, Micheal Mulvey, James Karlowsky, George G. Zhanel, Daryl Hoban

PDF 412Kb Download

 

Risk Factors for Multi- and Extreme-Drug Resistance in 4806 Escherichia coli Isolates in Canadian Hospitals – Results from CANWARD 2007-2010

Philippe Lagacé-Wiens, Melanie Decorby, Patricia Simner, Franil Tailor, Heather Adam, James Karlowsky, George G. Zhanel, Daryl Hoban

PDF 257Kb Download

 

Activity of Doripenem and Other Carbapenems against 23,243 Pathogens Isolated from Canadian Hospitals: CANWARD 2007 - 2010

N. Laing, H. Adam, B. Weshnoweski, R. Vashisht, M. Decorby, F. Tailor, P. Simner, D. J. Hoban and G. G. Zhanel

PDF 196Kb Download

 

Antibiotic Resistance in Lower Respiratory Tract Infection (LRTI) Pathogens: A National Canadian Perspective: The CANWARD Study 2007-2010

D. J. Hoban, H. Adam, M. Decorby, B. Weshnoweski, R. Vashisht, J.A. Karlowsky, The Canadian Antimicrobial Resistance Alliance (Cara) and G. G. Zhanel

PDF 142Kb Download

 

Prevalence of Antimicrobial Resistance among Clinical Isolates of Bacteroides fragilis group in Canada in 2010-2011: CANWARD Surveillance Study

S. Sepehri, R. Vashisht, B. Weshnoweski, J. A. Karlowsky, A. J. Walkty, H. J. Adam, D. J. Hoban, And G. G. Zhanel

PDF 219Kb Download

 

ICAAC 2010

Activity of Doripenem and Other Carbapenems Against 18,538 Pathogens Isolated from Canadian Hospitals: CANWARD 2007-2009

G.G Zhanel, M. DeCorby, N. Lang, P. Simner, F. Tailor, H. Adam, J.A. Karlowsky, P. Lagacé-Wiens and D.J. Hoban

PDF 143Kb Download

 

NXL103 (Linopristin/Flopristin) Activity Against Pathogens Isolated from Patients in Canadian Hospitals: CANWARD 2009

J.A Karlowsky, P. Lagacé-Wiens, A. Wierzbowski, D.J. Hoban, G.G Zhanel

PDF 123Kb Download

 

Comparison of Community-Associated and Healthcare-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) in Canada: CANWARD 2007-2009

K.A. Nichol, H.J. Adam, M. McCracken, L. Mataseje, M.R. Mulvey, S. Kost, M.R DeCorby, D.J. Hoban and G.G Zhanel

PDF 233Kb Download

 

Activity of Telavancin against Gram-Positive Cocci from Canadian Hospitals: CANWARD 2007-2009

K.A Nichol, N. Laing, B. Weshnoweski, R. Vashisht, M.R DeCorby, D.J. Hoban and G.G. Zhanel

PDF 131Kb Download

 

Vancomycin MIC Creep in Staphylococcus aureus in Canada: Analysis of 3587 Isolates from 2007-2009

P.R.S. Lagacé-Wiens, M. DeCorby, K, Nichol, H. Adam, J. Karlowsky, G.G Zhanel and D. Hoban

PDF 233Kb Download

 

Antibiotic Resistance in Lower Respiratory Tract Infection (LRTI) Pathogens: A National Canadian Perspective: The CANWARD Study 2007-2009

D.J. Hoban, M. DeCorby, B. Weshnoweski, R. vashisht, J.A. Karlowsky, the Canadian Antimicrobial Resistance Alliance (CARA) and G.G Zhanel

PDF 135Kb Download

 

Antimicrobial Resistance in 18,538 Pathogens from Canadian Hospitals: CANWARD Study 2007-2009

G.G. Zhanel, B. Weshnoweski, R. Vashisht, M. DeCorby, H. Adam, M. R. Mulvey, M. McCracken, K. Nichol, F. Tailor, A. Wierzbowski, P. Simner, P. Lagacé-Wiens, A. Walkty, J.A. Karlowsky, F. Schweizer, Canadian Antimicrobial Resistance Alliance (CARA) and D.J. Hoban

PDF 135Kb Download

 

Pharmacodynamic Activity of Ceftobiprole Compared to Vancomycin vs. Enterococcus faecalis Using an In Vitro Model

G.G. Zhanel, N. Laing, L. Cox, E. Rossnagel, D. Voth, J.A. Karlowsky and D.J. Hoban

PDF 168Kb Download

 

Activity of Daptomycin, Vancomycin and Linezolid against 6,951 Gram-positive Pathogens Isolated from Canadian Hospitals: CANWARD 2007-2009

G.G. Zhanel, R. Vashisht, B. Weshnoweski, M. DeCorby, H. Adam, K. Nichol, J.A. Karlowsky and D.J. Hoban

PDF 131Kb Download

 

Macrolide-Resistant Streptococcus pneumoniae (Mac-R SPN) in Canada: 1998 to 2008 Experience

A.K. Wierzbowski, J.A. Karlowsky, N. Laing, D.J. Hoban, G.G. Zhanel and the Canadian Antimicrobial Resistance Alliance (CARA)

PDF 131Kb Download

 

Prevalence of Antimicrobial Restistance among Urinary Tract Pathogens Isolated in Canada from 2007 to 2009: Results from the CANWARD Sureillance Study

J.A. Karlowsky, M.R. DeCorby, R. Vashisht, B. Weshnoweski, P. Lagacé-Wiens, H.A. Adam, K. Nichol, A. Walkty, D.J. Hoban and G.G. Zhanel

PDF 131Kb Download

 

 

Activity of Daptomycin, Vancomycin and Linezolid against 6,951 Gram-positive Pathogens Isolated from Canadian Hospitals: CANWARD 2007-2009

G.G. Zhanel, R. Vashisht, B. Weshnoweski, M. DeCorby, H. Adam, K. Nichol, J.A. Karlowsky and D.J. Hoban

PDF 131Kb Download

 

ICAAC 2009

Activity of Dalbavancin Against S. aureus, S. epidermidis, Enterococcus spp. and S. pneumoniae Isolated from Canadian Hospitals: Results of CANWARD 2007-2008

B. Weshnoweski, R. Vashisht, F. Tailor, M. DeCorby, L.Bittner, J.A.Karlowsky, G.G. Zhanel and D.J. Hoban

PDF 4.5Mb Download

 

Activity of Doripenem and Other Carbapenems Against 10,035 Canadian Hospital Pathogens: CANWARD 2007 and 2008

D.J. Hoban, M. DeCorby, P. Baudry, A. Wierzbowski, J.A. Karlowsky and G.G. Zhanel

PDF 3.2Mb Download

 

Activity of Doripenem (DOR) Against Molecularly Characterized AmpC, ESBL Producing and Carbapenem Reduced-Susceptible (CRS) E. coli (EC) Across Canada

F. Tailor, P.J. Baudry, B. Weshnoweski, R. Vashisht, J.A. Karlowsky, P. Lagacé-Wiens, D.J. Hoban and G.G. Zhanel

PDF 2.9Mb Download

 

Antimicrobial Resistance in 13,163 Pathogens from Canadian Hospitals: CANWARD Study 2007 and 2008

G.G. Zhanel, M. DeCorby K. Nichol, N. Laing, B. Weshnoweski, R. Vashisht, F. Tailor, A. Wierzbowski, P. Baudry, P. Lagacé-Wiens, A. Walkty, H. Adam, J.A. Karlowsky, M. McCracken, M.R. Mulvey, Canadian Antimicrobial Resistance Alliance (CARA), and D.J. Hoban

PDF 4.0Mb Download

 

In Vitro Activity of Ceftobiprole Against 10,035 Pathogens Obtained from Patients in Canadian Hospitals: CANWARD 2007 and 2008

G.G. Zhanel, M. DeCorby, R. Vashisht, P. Lagacé-Wiens, K. Nichol, D.J. Hoban and J.A. Karlowsky.

PDF 3.3Mb Download

 

Comparison of Community-Associated (CA) and Healthcare-Associated (HA) Methicillin-Resistant Staphylococcus aureus (MRSA) in Canada: Results from CANWARD 2008

K.A. Nichol, M. DeCorby, M. McCracken, M.R. Mulvey, H.J. Adam, D.J. Hoban, the Canadian Antimicrobial Resistance Alliance (CARA) and G.G. Zhanel

PDF 1.1Mb Download

 

Canadian Staphylococcus aureus Isolates Show Vancomycin MIC Creep Over Time

Philippe Lagacé-Wiens, Melanie R. DeCorby, Kim Nichol, Heather Adam, James A. Karlowsky, George G. Zhanel and Daryl J. Hoban

PDF 1.8Mb Download

 

AmpC Beta-Lactamase-Producing Escherichia coli from Canadian Hospitals: CANWARD 2007 & 2008

P.J. Baudry, S. Peterson, P. Lagacé-Wiens, M.R. Mulvey, G.G. Zhanel and D.J. Hoban

PDF 2.9Mb Download

 

Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae (ESBL-ENT) from Patients in Canadian Hospitals: CANWARD 2007 & 2008

P.J. Baudry, M. McCracken, P. Lagacé-Wiens, M.R. Mulvey, G.G. Zhanel, D.J. Hoban and the Canadian Antimicrobial Resistance Alliance (CARA).

PDF 4.4Mb Download